Washington, DC-Rapamycin, aka sirolimus, a drug already used as an immunosuppressant agent in kidney transplantation, may prove to be an effective treatment for autosomal dominant polycystic kidney ...
Researchers at the Max Planck Institute for Biology of Aging have discovered that the combination of the two cancer drugs, rapamycin and trametinib, significantly extends the lifespan of mice. The ...
University of Oxford-led research finds low-dose rapamycin functions as a genomic protector in aging human immune cells, lowering DNA damage. Subscribe to our newsletter for the latest sci-tech news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results